| Women's Internal Medicine Inc. | |
|
1672 S County Trl Suite 303 East Greenwich RI 02818-5098 | |
| (401) 884-0020 | |
| (401) 884-0019 |
| Full Name | Women's Internal Medicine Inc. |
|---|---|
| Speciality | Internal Medicine |
| Location | 1672 S County Trl, East Greenwich, Rhode Island |
| Authorized Official Name and Position | Flora Treger (PRESIDENT) |
| Authorized Official Contact | 4018840020 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Women's Internal Medicine Inc. 1672 S County Trl Suite 303 East Greenwich RI 02818-5098 Ph: (401) 884-0020 | Women's Internal Medicine Inc. 1672 S County Trl Suite 303 East Greenwich RI 02818-5098 Ph: (401) 884-0020 |
| NPI Number | 1386690394 |
|---|---|
| Provider Enumeration Date | 05/25/2006 |
| Last Update Date | 05/06/2022 |
| Medicare PECOS PAC ID | 8527047943 |
|---|---|
| Medicare Enrollment ID | O20040719000309 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386690394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Gina M Natalizia Huntoon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144391517 PECOS PAC ID: 6002894037 Enrollment ID: I20040707001446 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
| Provider Name | Kristin M Poshkus |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558317008 PECOS PAC ID: 2264411768 Enrollment ID: I20040719000182 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
| Provider Name | Leah Marano |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245456011 PECOS PAC ID: 2466649264 Enrollment ID: I20101206000880 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
| Provider Name | Mariola Nowak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1508812165 PECOS PAC ID: 4587711239 Enrollment ID: I20101220000555 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
| Provider Name | Flora Treger |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1952355349 PECOS PAC ID: 9133276884 Enrollment ID: I20101220000886 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
| Provider Name | Dana R Chofay |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1811943525 PECOS PAC ID: 3678620325 Enrollment ID: I20101221001163 |
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
News Archive
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according to a prospective cohort study led by Children's National Health System research-clinicians.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
A multi-disciplinary group of researchers at the University of Maryland School of Medicine have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.
COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
› Verified 9 days ago
Philip M. Trupiano, Do, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1351 S County Trl, Building 2 Suite 220, East Greenwich, RI 02818 Phone: 401-421-8800 Fax: 401-273-5610 | |
Christopher T Peters, Do, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2358 S County Trl, East Greenwich, RI 02818 Phone: 401-886-6000 Fax: 401-886-6002 | |
Ryan S Allen Do Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2358 S County Trl, East Greenwich, RI 02818 Phone: 401-886-6000 Fax: 401-886-6002 | |
Charles L Cronin Iii Do Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2358 S County Trl, East Greenwich, RI 02818 Phone: 401-886-6000 Fax: 401-886-6002 | |
Your Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1407 S County Trl, Unit 422, East Greenwich, RI 02818 Phone: 401-398-2656 | |
Herbert J Brennan Do Ltd Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2358 S County Trl, East Greenwich, RI 02818 Phone: 401-886-6000 Fax: 401-886-6002 | |
Ia Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1050 Main St Unit 15, East Greenwich, RI 02818 Phone: 401-363-2445 Fax: 401-371-4418 |